And vice verca with you. So biased, you lost your amenableness.
Tell me and others if Oxigene will make it all the way with Zybrestat on ATC? What are the odds ? Whats a first to market VDA worth ?
Remember, someone just put a 10 million dollar + bet that ATC interim data will be good enough for approval. In case you dont know its a pretty though climate out there for biocompanies, wake up call....
And please give your opnion on Zybrestat/Avastin + Chemo on NSCLC.